Piperacillin Sodium | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Piperacillin Sodium
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Piperacillin Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 14 USDMF, 14 CEP/COS, 13 JDMF, 10 KDMF, 13 NDC API, 8 Listed Suppliers, $ API Reference Price

46 API Suppliers
14 USDMF
14 CEP/COS
13 JDMF
10 KDMF
13 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

173 FDF Dossiers, 70 FDA Orange Book, 53 Europe, 12 South Africa, 38 Listed Dossiers

173 FDF Dossiers
70 FDA Orange Book
53 Europe
12 South Africa
38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML
INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML
INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Kirsch Pharma, 1 Actylis, 4 Roquette

1 SPI Pharma
3 Kirsch Pharma
1 Actylis
4 Roquette

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 2 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers, 1 API Stability Enhancers

6 Parenteral
2 Fillers, Diluents & Binders
1 Thickeners and Stabilizers
1 API Stability Enhancers

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 51 Regulatory FDF Prices, 7 Annual Reports

24 US Medicaid Prescriptions
51 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

7 APIs, 5 FDF Dossiers

7 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 7 Others

2 EDQM
4 USP
7 Others

$ API Ref.Price (USD/KG) : 107 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Pfizer Canada Inc.

filter Patent Reset all filters

6 All

01 32145078

02 32464258

filter Product Reset all filters

6 All

01 6Piperacillin Sodium | Tazobactam Sodium

filter Dosage Reset all filters

6 All

01 6Powder for Reconstitution

filter Exp Date Reset all filters

6 All

01 32014-11-02

02 32024-04-08

Product Main Page

01

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2145078

Filing Date : 1994-11-02

Strength per Unit : 2.25g vial (2g / 0.25g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2464258

Filing Date : 2004-04-08

Strength per Unit : 2.25g vial (2g / 0.25g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2145078

Filing Date : 1994-11-02

Strength per Unit : 3.375g vial (3g / 0.375g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2464258

Filing Date : 2004-04-08

Strength per Unit : 3.375g vial (3g / 0.375g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2145078

Filing Date : 1994-11-02

Strength per Unit : 4.5g vial (4g / 0.5g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2014-11-02

Date Granted : 1999-08-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pfizer Canada Inc.

Piperacillin Sodium, Tazobactam Sodium

Peptide Process CMC

Not Confirmed

Pfizer Canada Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Piperacillin Sodium, Tazobactam Sodium

Brand Name : TAZOCIN

Patent Number : 2464258

Filing Date : 2004-04-08

Strength per Unit : 4.5g vial (4g / 0.5g)

Dosage Form : Powder for Reconstitution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2024-04-08

Date Granted : 2005-06-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!